Treatment of Non-small Cell Lung Cancer Stage I and Stage II, Chest, vol.132, issue.3, pp.234-242, 2007. ,
DOI : 10.1378/chest.07-1378
Revisions in the International System for Staging Lung Cancer, Chest, vol.111, issue.6, pp.1710-1717, 1997. ,
DOI : 10.1378/chest.111.6.1710
Destruction par??radiofr??quence des??tumeurs pulmonaires et??osseuses, Cancer/Radioth??rapie, vol.10, issue.6-7 ,
DOI : 10.1016/j.canrad.2006.07.014
Le traitement par radiofr??quence des tumeurs pulmonaires, Revue de Pneumologie Clinique, vol.67, issue.4, pp.238-281, 2011. ,
DOI : 10.1016/j.pneumo.2011.04.003
Critical review of nonsurgical treatment options for stage I non-small cell lung cancer. The Oncologist, pp.309-328, 2008. ,
Lung Cancer???Where Are We Today?, American Journal of Respiratory and Critical Care Medicine, vol.166, issue.9, pp.1166-96, 2002. ,
DOI : 10.1164/rccm.200202-070SO
Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.82, issue.19 suppl, pp.69-90, 2011. ,
DOI : 10.3322/caac.20107
Recommandations professionnelles Cancer du poumon non à petites cellules ,
Epidemiology of Lung Cancer, Chest, vol.143, issue.5, pp.1-29, 2013. ,
DOI : 10.1378/chest.12-2345
Radiothérapie en conditions stéréotaxiques des tumeurs broncho-pulmonaires. Cancer/Radiothérapie, pp.297-307, 2014. ,
Respiratory cancer and exposure to arsenic, chromium, nickel, and polycyclic aromatic hydrocarbons, Clinics in Occupational and Environmental Medicine, vol.2, issue.4, pp.779-801, 2002. ,
DOI : 10.1016/S1526-0046(02)00056-0
Inherited Susceptibility to Common Cancers, New England Journal of Medicine, vol.359, issue.20, pp.2143-53, 2008. ,
DOI : 10.1056/NEJMra0802968
Cancer incidence and mortality in France over the period, Rev Epidemiol Sante Publique, vol.56, pp.159-75, 1980. ,
Treatment of Small Cell Lung Cancer, Chest, vol.143, issue.5, pp.400-419, 2013. ,
DOI : 10.1378/chest.12-2363
The Stage Classification of Lung Cancer, 191S-210S. 17. Hoboken, 2013. ,
DOI : 10.1378/chest.12-2354
The New Lung Cancer Staging System, Chest, vol.136, issue.1, pp.260-71, 2009. ,
DOI : 10.1378/chest.08-0978
The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung Cancer, Journal of Thoracic Oncology, vol.2, issue.8, pp.686-93, 2007. ,
DOI : 10.1097/JTO.0b013e31811f4703
URL : https://hal.archives-ouvertes.fr/inserm-00372201
Chirurgie des tumeurs pulmonaires de stade I. Cancer/Radiothérapie, 2011. ,
Local irradiation alone for peripheral Stage I lung cancer: Could we omit the elective regional nodal irradiation?, International Journal of Radiation Oncology*Biology*Physics, vol.34, issue.2, pp.297-302, 1996. ,
DOI : 10.1016/0360-3016(95)00227-8
Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients, Radiotherapy and Oncology, vol.42, issue.1, pp.31-37, 1997. ,
DOI : 10.1016/S0167-8140(96)01828-2
A Systematic Overview of Radiation Therapy Effects in Non-Small Cell Lung Cancer, Acta Oncologica, vol.56, issue.271, pp.5-6493, 2003. ,
DOI : 10.1093/jnci/86.9.673
Elective nodal failures are uncommon in medically inoperable patients with Stage I non???small-cell lung carcinoma treated with limited radiotherapy fields, International Journal of Radiation Oncology*Biology*Physics, vol.56, issue.2, pp.342-349, 2003. ,
DOI : 10.1016/S0360-3016(02)04614-X
EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung, Lung Cancer, vol.81, issue.3, 2013. ,
DOI : 10.1016/j.lungcan.2013.05.019
Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, Journal of Thoracic Oncology, vol.8, issue.3, pp.346-51, 2013. ,
DOI : 10.1097/JTO.0b013e31827e1f83
Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer New techniques of tumor ablation (microwaves, electroporation), J Thorac Oncol. 2012 J Radiol, vol.792, issue.129, pp.1807-14789, 2011. ,
Pulmonary Resection for Metastases of Colorectal Adenocarcinoma, The Annals of Thoracic Surgery, vol.89, issue.2, pp.375-80, 2010. ,
DOI : 10.1016/j.athoracsur.2009.10.005
Is there a role for pneumonectomy in pulmonary metastases?, The Annals of Thoracic Surgery, vol.68, issue.6, pp.2039-2082, 1999. ,
DOI : 10.1016/S0003-4975(99)01151-0
Traitement par radiofr??quence des tumeurs pulmonaires, Revue des Maladies Respiratoires Actualit??s, vol.2, issue.3, pp.247-51, 2010. ,
DOI : 10.1016/S1877-1203(10)70071-9
Effect of Vessel Size on Creation of Hepatic Radiofrequency Lesions in Pigs, American Journal of Roentgenology, vol.178, issue.1, pp.47-51, 2002. ,
DOI : 10.2214/ajr.178.1.1780047
Massive Hemorrhage During Radiofrequency Ablation of a Pulmonary Neoplasm, Anesthesia & Analgesia, vol.94, issue.5, pp.1149-51, 2002. ,
DOI : 10.1097/00000539-200205000-00016
Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates, The Journal of Thoracic and Cardiovascular Surgery, vol.125, issue.4, pp.929-966, 2003. ,
DOI : 10.1067/mtc.2003.18
Thermoablation par radiofréquence des lésions pulmonaires, Rev Mal Respir Actual, 2013. ,
DOI : 10.1016/s1877-1203(13)70447-6
Fluorine- 18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: Preliminary results, Annals of Nuclear Medicine, vol.28, issue.2, pp.115-136, 2006. ,
DOI : 10.1007/BF02985623
Thermal ablation of lung tumors. Tech Vasc Interventional Rad, pp.102-115, 2007. ,
Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study, European Journal of Nuclear Medicine and Molecular Imaging, vol.18, issue.3, pp.1817-1844, 2013. ,
DOI : 10.1007/s00259-013-2521-9
Hospital: a review of 10 years of experience, Acta Med Okayama, vol.65, issue.43, pp.287-97, 2011. ,
minimum follow-up of 1 year: prospective evaluation. Radiology Chamming's Thermal ablation: tolerance and efficacy in a population mostly composed of primary lung cancers Risk factors involved in the development of pneumothorax during radiofrequency ablation of lung neoplasms, Midterm local efficacy and survival after radiofrequency ablation of lung tumors with, pp.587-96885, 2006. ,
Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study), The Lancet Oncology, vol.9, issue.7, pp.621-629, 2008. ,
DOI : 10.1016/S1470-2045(08)70155-4
Functional evaluation of the lung resection candidate, European Respiratory Journal, vol.11, issue.1 ,
DOI : 10.1183/09031936.98.11010198
Radiofrequency ablation for non-small-cell lung cancer in a single-lung patient: Case report and review of the literature, Lung Cancer, vol.80, issue.3, pp.341-344, 2013. ,
DOI : 10.1016/j.lungcan.2013.02.003
A systematic review of radiofrequency ablation for lung tumors Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. Radiology, Ann Surg Oncol. Feb, vol.15258, issue.522, pp.1765-74635, 2008. ,
Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: Results of a prospective trial, The Annals of Thoracic Surgery, vol.62, issue.1, pp.213-219, 1996. ,
DOI : 10.1016/0003-4975(96)00253-6
Pulmonary metastasectomy in colorectal cancer, British Journal of Surgery, vol.133, issue.Suppl 2, 2008. ,
DOI : 10.1002/bjs.9174
Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases--the International Registry of Lung Metastases, Zentralblatt Für Chir, vol.124, issue.2, pp.96-103, 1999. ,
Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases. Cancer Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases, pp.2106-2120, 2010. ,
Comparison of Survival after Sublobar Resections and Ablative Therapies for Stage I Non???Small Cell Lung Cancer, Journal of the American College of Surgeons, vol.211, issue.1, pp.37-4968, 2010. ,
DOI : 10.1016/j.jamcollsurg.2010.03.020
Long-Term Results of Radiofrequency Ablation Treatment of Stage I Non-small Cell Lung Cancer: A Prospective Intention-to-Treat Study, Journal of Thoracic Oncology, vol.6, issue.12, pp.2044-51, 2011. ,
DOI : 10.1097/JTO.0b013e31822d538d
Percutaneous radiofrequency ablation for clinical stage I non???small cell lung cancer: Results in 20 nonsurgical candidates, The Journal of Thoracic and Cardiovascular Surgery, vol.134, issue.5, pp.1306-1318, 2007. ,
DOI : 10.1016/j.jtcvs.2007.07.013
Pulmonary Radiofrequency Ablation: Long-term Safety and Efficacy in 153 Patients, Radiology, vol.243, issue.1, 2007. ,
DOI : 10.1148/radiol.2431060088
Percutaneous CT-Guided Radiofrequency Ablation as Supplemental Therapy After Systemic Chemotherapy for Selected Advanced Non???Small Cell Lung Cancers, American Journal of Roentgenology, vol.201, issue.6, pp.1362-1369, 2013. ,
DOI : 10.2214/AJR.12.10511
Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies, J Thorac Dis, vol.3, issue.3, pp.189-96, 2011. ,
Guide des procédures de radiothérapie externe, 2007. ,
Which Is the Optimal Biologically Effective Dose of Stereotactic Body Radiotherapy for Stage I Non???Small-Cell Lung Cancer? A Meta-Analysis, International Journal of Radiation Oncology*Biology*Physics, vol.81, issue.4, pp.305-321, 2011. ,
DOI : 10.1016/j.ijrobp.2011.04.034
Comparison of the effectiveness of radiotherapy with photons, protons and carbonions for non-small cell lung cancer: A meta-analysis, Radiother Oncol. 2010, vol.95, issue.1, pp.32-40 ,
The curative treatment by radiation therapy alone of Stage I non-small cell lung cancer in a geriatric population, Lung Cancer, vol.32, issue.1, pp.71-80, 2001. ,
DOI : 10.1016/S0169-5002(00)00199-9
Radioth??rapie st??r??otaxique des cancers broncho-pulmonaires non ?? petites cellules??: d???un concept ?? une r??alit?? clinique. Actualit??s en 2011, Cancer/Radioth??rapie, vol.15, issue.6-7, pp.6-7522, 2011. ,
DOI : 10.1016/j.canrad.2011.07.241
Maladie oligom??tastatique, un nouveau concept??: irradiation en conditions st??r??otaxiques de m??tastases pulmonaires. Revue de la litt??rature, Cancer/Radioth??rapie, vol.16, issue.5-6, pp.5-6351, 2012. ,
DOI : 10.1016/j.canrad.2012.07.184
Evaluation of Trends in the Cost of Initial Cancer Treatment, JNCI Journal of the National Cancer Institute, vol.100, issue.12, pp.888-97, 2008. ,
DOI : 10.1093/jnci/djn175
Effectiveness of Radiation Therapy for Elderly Patients with Unresected Stage I and II Non???Small Cell Lung Cancer, American Journal of Respiratory and Critical Care Medicine, vol.181, issue.3, pp.264-273, 2010. ,
DOI : 10.1164/rccm.200907-1064OC
Predicting Radiation Pneumonitis After Stereotactic Ablative Radiation Therapy in Patients Previously Treated With Conventional Thoracic Radiation Therapy, International Journal of Radiation Oncology*Biology*Physics, vol.84, issue.4, pp.1017-1040, 2012. ,
DOI : 10.1016/j.ijrobp.2012.02.020
Stereotactic Body Radiation Therapy for Re-irradiation of Persistent or Recurrent Non-Small Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.88, issue.5, pp.1114-1123, 2014. ,
DOI : 10.1016/j.ijrobp.2014.01.012
Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.3, pp.1149-56, 2012. ,
DOI : 10.1016/j.ijrobp.2011.03.005
No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy for Early- Stage Peripheral Non-Small Cell Lung Cancer: An Analysis of RTOG 0236, International Journal of Radiation Oncology*Biology*Physics, vol.88, issue.5, pp.1092-1101 ,
DOI : 10.1016/j.ijrobp.2013.12.050
Lack of a Dose-Effect Relationship for Pulmonary Function Changes After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.85, issue.4, pp.1074-81, 2013. ,
DOI : 10.1016/j.ijrobp.2012.09.016
Stereotactic Body Radiation Therapy in Multiple Organ Sites, Journal of Clinical Oncology, vol.25, issue.8, pp.947-52, 2007. ,
DOI : 10.1200/JCO.2006.09.7469
Treatment of stage I NSCLC in elderly patients: A population-based matched-pair comparison of stereotactic radiotherapy versus surgery, Radiotherapy and Oncology, vol.101, issue.2, pp.240-244, 2011. ,
DOI : 10.1016/j.radonc.2011.06.029
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis Non-surgical treatment of lung cancer: personalised stereotactic ablative radiotherapy, Lancet Oncol. Department of Clinical Oncology Hong Kong Med J, vol.13, issue.88, pp.802-811, 1989. ,
Les nouveautés épidémiologiques du cancer bronchique : les non-fumeurs, les femmes, les fumeurs de cannabis Rev Mal Respir Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group, BMJ, vol.24, issue.91, pp.10-15, 1995. ,
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy, Annals of Oncology, vol.10, issue.3, pp.295-303, 1999. ,
DOI : 10.1023/A:1008319506107
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment, Seminars in Radiation Oncology, vol.13, issue.3, pp.176-81, 2003. ,
DOI : 10.1016/S1053-4296(03)00031-6
Median follow-up in clinical trials., Journal of Clinical Oncology, vol.9, issue.1, pp.191-193, 1991. ,
DOI : 10.1200/JCO.1991.9.1.191
??pid??miologie du cancer bronchique primitif??: aspects classiques et nouveaut??s, Revue des Maladies Respiratoires, vol.28, issue.8, pp.1048-58, 2011. ,
DOI : 10.1016/j.rmr.2010.12.015
Épidémiologie et facteurs de risque des cancers bronchiques primitifs. EMC -Pneumol, pp.7-18, 2004. ,
Second Lung Cancers in Patients After Treatment for an Initial Lung Cancer, JNCI Journal of the National Cancer Institute, vol.90, issue.18, pp.1335-1380, 1998. ,
DOI : 10.1093/jnci/90.18.1335
Lung Radiofrequency Ablation for the Treatment of Unresectable Recurrent Non-Small-Cell Lung Cancer After Surgical Intervention, CardioVascular and Interventional Radiology, vol.122, issue.3, pp.563-572 ,
DOI : 10.1007/s00270-011-0220-0
Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors. Cancer, 2006. ,
Primary Non???Small Cell Lung Cancer: Review of Frequency, Location, and Time of Recurrence after Radiofrequency Ablation, Radiology, vol.254, issue.1, pp.301-308, 2010. ,
DOI : 10.1148/radiol.00000090174
Comparison of Survival Rate in Primary Non-Small-Cell Lung Cancer Among Elderly Patients Treated With Radiofrequency Ablation, Surgery, or Chemotherapy, CardioVascular and Interventional Radiology, vol.116, issue.9, 2012. ,
DOI : 10.1007/s00270-011-0194-y
Chirurgie des cancers bronchopulmonaires apr??s traitement d???un premier cancer, Revue des Maladies Respiratoires, vol.30, issue.5, 2013. ,
DOI : 10.1016/j.rmr.2013.01.005
Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non?Small-Cell Lung Cancer, Focused Update J Clin Oncol, 2009. ,
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial, The Lancet Oncology, vol.13, issue.3, pp.247-55, 2012. ,
DOI : 10.1016/S1470-2045(12)70063-3